FDA grants full approval to the Pfizer-BioNTech COVID vaccine | WHAT REALLY HAPPENED X-Frame-Options: DENY X-Frame-Options: SAMEORIGIN

FDA grants full approval to the Pfizer-BioNTech COVID vaccine

Federal regulators on Monday gave full approval to the Pfizer COVID-19 vaccine, according to reports.

The Food and Drug Administration approved the company’s two-dose shot, the Washington Post first reported, in a step that could lead more businesses and institutions to enact vaccine requirements. Some experts have criticized the FDA for not green lighting the effective vaccine sooner, as a highly contagious Delta variant spreads in the United States.

Approval for Pfizer’s two-dose vaccine was originally scheduled for Labor Day but was moved up due to a spike in cases, according to the New York Times.

The company was granted emergency use authorization in December, becoming the first COVID shot to get the green light.

Comments

SHARE THIS ARTICLE WITH YOUR SOCIAL MEDIA